Study provides the first data on leadless pacemakers in a pediatric population in a real-world setting.

As of April 1, 2023, families covered by these Pennsylvania health insurance plans need to submit a renewal when it is due.

Using 3D imaging, researchers in the Cardiac Center at Children’s Hospital of Philadelphia (CHOP) have found that patients with hypoplastic left heart syndrome (HLHS) experiencing moderate to severe tricuspid regurgitation (TR) have structural differences in their tricuspid valve.

What do a NICU nurse, adolescent medicine doctor, occupational therapy student, surgical coordinator, clinical research assistant, art teacher, dentist, university student, human resources coordinator, enterprise improvement adviser, CHOP Foundation associate director and pediatric resident have in common? 

Children’s Hospital of Philadelphia (CHOP) ‘s Shakeeb Akhter, Senior Vice President (SVP) & Chief Information Officer (CIO), has been named to the Philadelphia Business Journal’s (PBJ) 2023 40 Under Forty list.

Findings demonstrate how a new computational method could effectively analyze phenotypes and identify similarities among patient populations.

The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia (CHOP) has again won an award from Press Ganey, a healthcare company that evaluates patient satisfaction.

Inactivating mutations in the beta cell KATP channels are the most common cause of congenital hyperinsulinism (HI), accounting for approximately 60% of all cases with known genotype. The beta cell KATP channels play a very important role in the regulation of insulin secretion by coupling the metabolic state of the cell to membrane potential.

Unrecognized or inadequately treated hyperinsulinism (HI) poses a high risk of adverse neurodevelopmental outcomes due to the combined insult of hypoglycemia and lack of alternate brain fuels.

The Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, with a high volume of approximately 80 congenital hyperinsulinism (HI) cases a year, sees a large share of unusual cases.